SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia.
作者信息
Lee Nicholas C J, Patel Bhavisha, Etra Aaron, Bat Taha, Ibrahim Ibrahim F, Vusirikala Madhuri, Chen Mingyi, Rosado Flavia, Jaso Jesse Manuel, Young Neal S, Chen Weina
机构信息
Department of Internal Medicine, and.
Department of Pediatrics, UT Southwestern Medical Center, Dallas TX.
出版信息
Blood Adv. 2022 Jul 12;6(13):3840-3843. doi: 10.1182/bloodadvances.2022007174.
Abstract
摘要
相似文献
1
SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia.与再生障碍性贫血和纯红细胞再生障碍相关的新型冠状病毒2型感染
Blood Adv. 2022 Jul 12;6(13):3840-3843. doi: 10.1182/bloodadvances.2022007174.
2
[Anemia due to hematopoietic disorders. 1. Aplastic anemia and pre red cell aplasia].[造血系统疾病所致贫血。1. 再生障碍性贫血和纯红细胞再生障碍性贫血]
Nihon Naika Gakkai Zasshi. 2006 Oct 10;95(10):2030-5. doi: 10.2169/naika.95.2030.
3
[Aplastic anemia and pure red cell aplasia: diagnosis and treatment].再生障碍性贫血和纯红细胞再生障碍性贫血：诊断与治疗
Rinsho Ketsueki. 2006 Mar;47(3):176-89.
4
THYMOMA and red cell aplasia.胸腺瘤与红细胞再生障碍。
Br Med J. 1959 May 2;1(5130):1174.
5
SARS-CoV-2 infection coincident with newly diagnosed severe aplastic anemia: A report of two cases.新型冠状病毒肺炎感染合并新诊断的重型再生障碍性贫血：两例报告
Pediatr Blood Cancer. 2022 Apr;69(4):e29433. doi: 10.1002/pbc.29433. Epub 2021 Nov 12.
6
[Aplastic anemia and pure red cell aplasia].再生障碍性贫血与纯红细胞再生障碍性贫血
Rinsho Ketsueki. 2012 Jan;53(1):4-14.
7
Red-cell aplasia and benign thymoma; studies on a case responding to prednisone.红细胞再生障碍与良性胸腺瘤；对一例泼尼松治疗反应的研究
Br Med J. 1959 May 2;1(5130):1154-6. doi: 10.1136/bmj.1.5130.1154.
8
[Diagnosis and therapy of aplastic anemia and pure red cell aplasia].再生障碍性贫血和纯红细胞再生障碍性贫血的诊断与治疗
Nihon Naika Gakkai Zasshi. 1990 May 10;79(5):588-92.
9
[Clinical study of ciclosporin in patients with aplastic anemia and pure red-cell aplasia].环孢素治疗再生障碍性贫血和纯红细胞再生障碍性贫血患者的临床研究
Rinsho Ketsueki. 1995 Mar;36(3):175-84.
10
[Acquired amegakaryocytic thrombocytopenia after thymectomy in a case of pure red cell aplasia associated with thymoma].[胸腺瘤伴纯红细胞再生障碍性贫血患者胸腺切除术后获得性无巨核细胞性血小板减少症]
Korean J Lab Med. 2010 Jun;30(3):244-8. doi: 10.3343/kjlm.2010.30.3.244.
引用本文的文献
1
New-onset hematologic disorders following COVID-19 vaccination: a systematic review.新型冠状病毒肺炎疫苗接种后新发血液系统疾病：一项系统综述
Clin Exp Vaccine Res. 2025 Apr;14(2):169-184. doi: 10.7774/cevr.2025.14.e20. Epub 2025 Apr 8.
2
Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms.新冠疫情背景下的再生障碍性贫血：感染、疫苗接种及病理生理机制
Ann Hematol. 2024 Dec;103(12):4989-5005. doi: 10.1007/s00277-024-06052-9. Epub 2024 Oct 23.
3
Multidisciplinary approaches to study anaemia with special mention on aplastic anaemia (Review).采用多学科方法研究贫血，特别提到再生障碍性贫血（综述）。
Int J Mol Med. 2024 Nov;54(5). doi: 10.3892/ijmm.2024.5419. Epub 2024 Sep 2.
4
Thrombocytosis and megakaryocyte changes associated with PRCA.与纯红细胞再生障碍性贫血相关的血小板增多症和巨核细胞变化。
Blood Adv. 2024 Jun 25;8(12):3058-3062. doi: 10.1182/bloodadvances.2023012309.
5
Clinical Signs and Treatment of New-Onset Bone Marrow Failure Associated SARS-CoV-2 Infection in Children: A Single Institution Prospective Cohort Study.儿童新型冠状病毒感染相关新发骨髓衰竭的临床体征与治疗：一项单机构前瞻性队列研究
Mediterr J Hematol Infect Dis. 2024 Mar 1;16(1):e2024034. doi: 10.4084/MJHID.2024.034. eCollection 2024.
6
Manifestation of Pancytopenia Associated with COVID-19 as Paroxysmal Nocturnal Hemoglobinuria (PNH) and Aplastic Anemia (AA).与新冠病毒疾病（COVID-19）相关的全血细胞减少表现为阵发性夜间血红蛋白尿（PNH）和再生障碍性贫血（AA）。
Hematol Rep. 2024 Jan 17;16(1):42-49. doi: 10.3390/hematolrep16010005.
7
Acquired aplastic anaemia after SARS-CoV-2 infection in China: a case report.中国新型冠状病毒感染后获得性再生障碍性贫血：一例报告
Front Pediatr. 2023 Nov 7;11:1277540. doi: 10.3389/fped.2023.1277540. eCollection 2023.
8
New-onset aplastic anemia after SARS-CoV-2 vaccination.接种 SARS-CoV-2 疫苗后出现再生障碍性贫血。
Int J Hematol. 2023 Dec;118(6):667-681. doi: 10.1007/s12185-023-03666-z. Epub 2023 Sep 28.
9
Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review.新型冠状病毒2型感染或疫苗接种后再生障碍性贫血：病例系列及文献综述
Blood Transfus. 2024 May;22(3):266-272. doi: 10.2450/BloodTransfus.500. Epub 2023 Sep 4.
10
Exacerbation of autoimmune hemolytic anemia associated with pure red cell aplasia after COVID-19: A case report.COVID-19 后与纯红细胞再生障碍相关的自身免疫性溶血性贫血加重：病例报告。
J Infect Chemother. 2023 Aug;29(8):787-791. doi: 10.1016/j.jiac.2023.04.002. Epub 2023 Apr 10.
本文引用的文献
1
SARS-CoV-2 infection coincident with newly diagnosed severe aplastic anemia: A report of two cases.新型冠状病毒肺炎感染合并新诊断的重型再生障碍性贫血：两例报告
Pediatr Blood Cancer. 2022 Apr;69(4):e29433. doi: 10.1002/pbc.29433. Epub 2021 Nov 12.
2
SARS-CoV-2 infection in aplastic anemia.再生障碍性贫血中的新型冠状病毒2型感染
Haematologica. 2022 Feb 1;107(2):541-543. doi: 10.3324/haematol.2021.279928.
3
Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae.病例31 - 2021：一名21岁咽痛、鼻出血和口咽瘀点的男性。
N Engl J Med. 2021 Oct 14;385(16):1511-1520. doi: 10.1056/NEJMcpc2027096.
4
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.巴瑞替尼治疗住院 COVID-19 成人患者的疗效和安全性（COV-BARRIER）：一项随机、双盲、平行分组、安慰剂对照的 3 期临床试验。
Lancet Respir Med. 2021 Dec;9(12):1407-1418. doi: 10.1016/S2213-2600(21)00331-3. Epub 2021 Sep 1.
5
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.托珠单抗治疗 COVID-19 住院患者的疗效（RECOVERY）：一项随机、对照、开放标签、平台试验。
Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0.
6
COVID-19 infection in patients with severe aplastic anaemia.重型再生障碍性贫血患者的新型冠状病毒肺炎感染
Br J Haematol. 2021 Jun;193(5):902-905. doi: 10.1111/bjh.17415. Epub 2021 Apr 29.
7
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
8
Aplastic Anemia.再生障碍性贫血
N Engl J Med. 2018 Oct 25;379(17):1643-1656. doi: 10.1056/NEJMra1413485.
9
The epidemiology of acquired aplastic anemia.获得性再生障碍性贫血的流行病学
Haematologica. 2008 Apr;93(4):489-92. doi: 10.3324/haematol.12855.
Zotero 插件